We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Watson-Marlow Fluid Technology Group Acquires ASEPCO Corporation
News

Watson-Marlow Fluid Technology Group Acquires ASEPCO Corporation

Watson-Marlow Fluid Technology Group Acquires ASEPCO Corporation
News

Watson-Marlow Fluid Technology Group Acquires ASEPCO Corporation

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Watson-Marlow Fluid Technology Group Acquires ASEPCO Corporation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Watson-Marlow Fluid Technology Group (WMFTG) has acquired Asepco through its parent company Spirax-Sarco Engineering plc, for £7.0 million. Asepco, based in California USA, specializes in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.

Asepco is a natural extension of the Watson-Marlow Fluid Technology Group fluid path product portfolio and further strengthens WMFTG’s already strong global presence in the biotechnology and pharmaceutical industries. Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.

There is clear synergy and a significant growth opportunity presented by bringing together Asepco's product range and WMFTG’s products to meet the needs of the rapidly growing biopharmaceutical market.

Asepco complements WMFTG’s range by utilizing patented, market-leading technology to improve sterility levels within the biotechnology production process. This improved process sterility reduces the risks surrounding validation in demanding contamination-free applications. This generates greater levels of confidence for our customers.

Jay Whalen, President of the Watson-Marlow Fluid Technology Group comments: "The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow's position in the biopharmaceutical market. This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise”.

Steve Joy, Asepco President will remain in his role. Steve brings a wealth of experience to WMFTG. Prior to joining Asepco, Steve had previous experience of founding and growing a business with Jensen Fittings.

Steve commented, “I am very excited to be part of the Watson-Marlow Fluid Technology Group and look to drive sales further with the expansive WMFTG sales network.”

Advertisement